These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 465827)

  • 1. Mathematical approaches to optimization of cancer chemotherapy.
    Zietz S; Nicolini C
    Bull Math Biol; 1979; 41(3):305-24. PubMed ID: 465827
    [No Abstract]   [Full Text] [Related]  

  • 2. A mathematical model of the development of drug resistance to cancer chemotherapy.
    Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of optimal drug administration strategies for cancer-chemotherapy in the framework of systems theory.
    Acharya RS; Sundareshan MK
    Int J Biomed Comput; 1984; 15(2):139-50. PubMed ID: 6724730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modelling: Forecasting cancer.
    Gammon K
    Nature; 2012 Nov; 491(7425):S66-7. PubMed ID: 23320294
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating and designing cancer chemotherapy treatment using mathematical models.
    Birkhead BG; Gregory WM; Slevin ML; Harvey VJ
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):3-8. PubMed ID: 3956557
    [No Abstract]   [Full Text] [Related]  

  • 6. Escalating drug delivery in cancer chemotherapy: a review of concepts and practice--Part 1.
    Gurney H; Dodwell D; Thatcher N; Tattersall MH
    Ann Oncol; 1993 Jan; 4(1):23-34. PubMed ID: 8435358
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer chemotherapy: optimal control using the Verhulst-Pearl equation.
    Swan GW
    Bull Math Biol; 1986; 48(3-4):381-404. PubMed ID: 3828564
    [No Abstract]   [Full Text] [Related]  

  • 8. On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).
    Skipper HE
    Bull Math Biol; 1986; 48(3-4):253-78. PubMed ID: 3828557
    [No Abstract]   [Full Text] [Related]  

  • 9. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
    Panetta JC
    Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical models in high-dose chemotherapy.
    Souhami RL; Gregory WM; Birkhead BG
    Antibiot Chemother (1971); 1988; 41():21-8. PubMed ID: 3245689
    [No Abstract]   [Full Text] [Related]  

  • 11. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some optimal control problems in cancer chemotherapy with a toxicity limit.
    Murray JM
    Math Biosci; 1990 Jun; 100(1):49-67. PubMed ID: 2134468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.
    Murray JM
    Math Biosci; 1994 Oct; 123(2):183-213. PubMed ID: 7827419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology.
    Park K
    Yonsei Med J; 2017 Jan; 58(1):1-8. PubMed ID: 27873489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical model of cancer chemotherapy with an optimal selection of parameters.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1990 May; 99(2):205-30. PubMed ID: 2134520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of optimal control theory in cancer chemotherapy.
    Swan GW
    Math Biosci; 1990 Oct; 101(2):237-84. PubMed ID: 2134485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumoral chemotherapy].
    Drochmans A
    Acta Clin Belg; 1974; 29(1):1-19. PubMed ID: 4596845
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of cell kinetics in cancer chemotherapy.
    Valeriote FA; Edelstein MB
    Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
    [No Abstract]   [Full Text] [Related]  

  • 19. Criteria for analyzing interactions between biologically active agents.
    Berenbaum MC
    Adv Cancer Res; 1981; 35():269-335. PubMed ID: 7041539
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.